Search for: "*carlton v. Price" Results 21 - 40 of 40
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Nov 2013, 5:53 am
Our next post will discuss case management considerations. [1] See, e.g., Unger v. [read post]
11 Nov 2013, 5:53 am
Our next post will discuss case management considerations. [1] See, e.g., Unger v. [read post]
22 Mar 2012, 12:06 pm by Raj Chohan
Dukes to reverse class certification in Price v. [read post]
6 Jan 2011, 7:17 am by Carolyn Elefant
They’re also default providers of important services like lawyers’ assistance programs and courses on starting a law firm that provide reasonably priced, jurisdiction-specific guidance. [read post]
9 Aug 2010, 7:13 am by Josh Wright
Hosken, Empirical Methods in Merger Analysis: Econometric Analysis of Pricing in FTC v. [read post]
23 May 2008, 1:03 am
- Generic manufacturers aggressively promote expensive doxofylline over price controlled equivalent theophylline: (Spicy IP), Middle East – Ranbaxy strengthens presence in Middle East region: (GenericsWeb), Scotland: Future funding of stem cell companies in Scotland dependent on EPO Enlarged Board of Appeals’ decision on stem cell patentability: (IP finance), South Africa: More on AIDS/access debate - Patrick Bond article on Thabo Mbeki’s AIDS policy: (Afro-I [read post]
3 Jul 2007, 6:22 am
There are now seven cases holding that FDA-approved warnings or other conduct is within the safe harbor for government authorized activity - the seventh being Prohias v. [read post]